Icecure Medical is trading at $1.85, down 5.13%, amid broad risk-asset pressure from rising Treasury yields and renewed inflation concerns.
- No new company-specific announcement was identified on September 23, 2026; the latest company release remains the September 10 China approval.
- The S&P 500 and Nasdaq Composite fell more than 0.5%, amid broader U.S. selling pressure.